The ambitions of NHS Digital’s e-nursing week and the Royal College of Nursing's (RCN) 'Every nurse an e-nurse' campaign are being realised by nurses across the UK, who are seeing the benefits of using digital health on the frontline by using Patientrack, a technology used by nursing staff to capture patient vital signs and alert doctors when urgent attention is needed, 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the continued momentum of its cutting-edge pathology diagnostics with the successful transformation of two fully digital pathology labs in Austria. The Pathology Institute in Hall and the Pathology Institute at Tirol Kliniken Innsbruck have fully digitized their diagnostic process with Philips IntelliSite Pathology Solution, 
VTT Technical Research Centre of Finland studied the implementation of a logistics robot system at the Seinäjoki Central Hospital in South Ostrobothnia. The aim is to reduce transportation costs, improve the availability of supplies and alleviate congestion on hospital hallways by running deliveries around the clock on every day of the week. 
Allscripts (NASDAQ:MDRX) has partnered with Elligo Health Research to assist clinicians to conduct clinical trial studies in their own clinics. Through the Allscripts / Elligo partnership, clinical trials managed by Clinical Research Organizations (CROs) will be available, bringing new treatments to patients across major therapeutic areas. Royal Philips (NYSE: PHG, AEX: PHIA) and HeartFlow, Inc. announced today that they have entered into a collaboration agreement with the goal of improving access to diagnostic and planning tools for interventional cardiologists evaluating and treating patients with suspected coronary artery disease (CAD). Under the agreement, Philips will promote the use of the 
labfolder and the German Accelerator Life Sciences (GALS), an initiative supported by the German Federal Ministry for Economic Affairs and Energy (BMWi), have announced the initiation of an extensive collaboration supporting the company's expansion into the North American markets. With thousands of users and a growing number of customers in the U.S. already, the newly established Cambridge office will accelerate those efforts and support customer relations. 
The Lyfebulb-Novo Nordisk Innovation Summit 2017 will recognize and empower international Patient Entrepreneurs with big ideas that disrupt the future of diabetes management. Patient Entrepreneurs have a unique ability to create value-adding disease management solutions beyond therapy. The aim is to support patient-driven innovation and laser-focus on improving the quality of life for those living with diabetes.